معرفی
Professor David Cairns is a leading academic in clinical trials research at the University of Leeds, Faculty of Medicine and Health, School of Medicine. He serves as Professor of Clinical Trials Research, Deputy Director of the Leeds Cancer Research UK Clinical Trials Unit (CTRU), and Director of Late Phase Trials in the Cancer Division. His work bridges biostatistics and oncology, with a focus on designing and analyzing large-scale confirmatory trials.
His educational background includes a PhD and MSc in Statistics from the University of Sheffield and a BSc in Mathematics from the University of Leeds.
David Cairns specializes in the design and analysis of cancer clinical trials, particularly in haematological malignancies such as multiple myeloma and chronic lymphocytic leukaemia, as well as solid tumours including colon, gastro-oesophageal, and urological cancers. He is passionate about developing efficient trial designs that incorporate biomarkers to define treatment pathways and enhance personalization. He actively promotes the integration of translational research within clinical trials to improve scientific value and inform future study designs.
The 15 most recent articles reflect a strong focus on methodological innovation in clinical trials, including platform trials, non-concurrent controls, biomarker-driven designs, and the integration of real-world data. His work combines statistical rigor with clinical relevance, particularly in oncology settings.
His scientific recognition includes the MRC Career Development Award in Biostatistics. He is also actively involved in national research governance through membership in key panels:
- Fellow of the Royal Statistical Society
- NCRI Multiple Myeloma Subgroup (Member)
- NIHR Clinical Trial Fellowship Panel (Member)
- NIHR Development and Skills Enhancement Fellowship Panel (Member)
- NIHR Doctoral Research Fellowship Panel (Deputy Chair)
- Cancer Research UK Expert Review Panel (Member)
David Cairns is deeply committed to student education and the training of future clinical researchers. He welcomes PhD applicants interested in clinical trials, biostatistics, and cancer research. He supervises postgraduate research and contributes to the academic development of junior researchers through mentorship and collaborative projects. His leadership roles indicate substantial grant oversight and management of large-scale research initiatives. He is embedded in the Leeds Institute of Clinical Trials Research, a multidisciplinary team dedicated to improving patient outcomes through high-quality trial design and execution.
He is affiliated with several research groups and institutes, primarily the Leeds Institute of Clinical Trials Research (Populations) and contributes to national and international efforts in advancing cancer clinical research methodology.
حوزههای پژوهشی
